Long-term survival advantage for women treated with pegylated liposomal doxorubicin compared with topotecan in a phase 3 randomized study of recurrent and refractory epithelial ovarian cancer
Autor: | Gordon, Alan N. *, Tonda, Margaret, Sun, Steven, Rackoff, Wayne |
---|---|
Zdroj: | In Gynecologic Oncology October 2004 95(1):1-8 |
Databáze: | ScienceDirect |
Externí odkaz: |